Although the activity tracking and consumer health market is growing more crowded every day, Casper de Clercq, an investor recently promoted to general partner at Norwest Venture Partners, said in the future it will be medical-focused, not consumer, wearable companies that offer the better return on investment.
Clercq has invested in consumer health companies, including Misfit and Basis, which were both acquired in the last couple years, as well as medical-focused companies, including iRhythm and Telcare. He recently spoke about his investments in an interview with the Silicon Valley Business Journal.
“It takes longer to develop the business and requires more resources, but ultimately I believe they are much more defensible and therefore valuable,” Clercq told the Sillicon Valley Business Journal. “A successful FDA trial, or FDA approval and positive clinical outcomes establish barriers to entry for competitors.”